This extensive study from the European Molecular Biology Laboratory (EMBL), examines the effects of more than 1000 human targeted drugs on 40 strains of the most dominant gut microbial species. It is published in the prestigious journal Nature, a reflection of the high quality of the research. Here is the abstract Here is the full article and here is the press release from EMBL. Other notably comments from the paper include:- Finally the high throughput screening technique which the study rests on was developed in a parallel study from EMBL, published at the same time in Nature Microbiology. Here is the abstract and here is the press release from EMBL. This is a very technical paper which most would probably not want to delve into, but its importance lies in the development of culture techniques in defined media which facilitate the detailed study of the major gut bacteria.